Guaranteed safety and effectiveness of Lepu SARS-CoV-2 Antigen Rapid test

Dear Client,

We are pleased to share with you the most updated news about our SARS-CoV-2 Antigen Rapid Test: Market performance follow-up studies have confirmed the safety and effectiveness of Lepu SARS-CoV-2 Antigen Rapid test.

To continuously track and verify the performance of SARS-CoV-2 Antigen Rapid test, LEPU Medical Technology has conducted several post market performance follow-up studies in Germany after obtaining the approval of BfArM for self-testing.

The post market performance follow-up studies include the performance for layman and professionals respectively. The diagnostic sensitivity was 91.30%, and the specificity was 100% in the study done by Biomex in April 2021. The diagnostic sensitivity was 95.90%, and the specificity was 100% in the study done by Biomex in June 2021. The test results were both acceptable for layman and professionals.

Lepu will constantly deliver high-quality and innovative products to keep addressing the global medical needs. Please feel free to let me know if you have any questions. Thanks!

Kind regards,

Lepu Medical Guaranteed safety and effectiveness of Lepu SARS-CoV-2 Antigen Rapid test